Elanco Animal Health IncorporatedELANNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank70
5Y CAGR-19.8%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-19.8%/yr
Long-term compound
Percentile
P70
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 6.98% |
| 2024 | 5.20% |
| 2023 | 1.87% |
| 2022 | -13.01% |
| 2021 | 12.84% |
| 2020 | 21.07% |
| 2019 | 9.53% |
| 2018 | -2.03% |
| 2017 | -5.30% |
| 2016 | -8.66% |